FSSAI Suspends Dior Pharmaceuticals Nutraceutical Licence

The Food Safety and Standards Authority of India (FSSAI) suspended the nutraceutical licence of Dior Pharmaceuticals on 30 July 2026. The suspension order followed findings of serious violations and deficient good manufacturing practices at the company’s nutraceutical plant in Punjab.

FSSAI and Nutraceutical Regulation

FSSAI is a statutory body established under the Food Safety and Standards Act, 2006. It regulates food safety in India, including nutraceuticals, which are products derived from food sources and used as dietary supplements or functional foods.

Good Manufacturing Practices in Food Plants

Good manufacturing practices, or GMP, are a set of standards for hygiene, sanitation, equipment maintenance, storage, and personnel practices in food and pharmaceutical facilities. Inspections at the Dior Pharmaceuticals plant found non-compliance in infrastructure, sanitation, pest control, storage practices, and personnel hygiene.

Licence Suspension and Compliance Requirements

FSSAI stated that the company failed to ensure the safety, quality, and traceability of its food products. All manufacturing activities at the site must stop immediately until full compliance is established and verified by the regulator.

Important Facts for Exams

• FSSAI functions under the Food Safety and Standards Act, 2006.
• Nutraceuticals are regulated as food products in India under the food safety framework.
• Good manufacturing practices cover hygiene, sanitation, storage, pest control, and personnel conduct.
• Traceability in food regulation refers to the ability to track a product through production and distribution stages.

Food Safety Enforcement

FSSAI can suspend or cancel licences when a food business operator violates safety and quality norms. Such regulatory action applies to manufacturing units that fail inspection standards under the food safety system in India.